Matthew Bambery has extensive work experience in finance and the healthcare industry. Matthew served as the Chief Financial Officer at Frontier Medical Group, a leading manufacturer and supplier of pressure injury prevention and infection prevention products. In this role, Matthew was responsible for managing the financial aspects of the company's portfolio, which includes renowned brands such as Repose, Toto, Sharpsafe, and eXchange. Prior to their time at Frontier, Matthew worked at PwC as a Transaction Services Director for thirteen years. Matthew also gained experience at AstraZeneca as an R&D Assistant.
Matthew Bambery began their education at Holy Family High School, where they attended from 1989 to 1994. Matthew then went on to study at King George V College from 1994 to 1996, but it is unclear what degree they pursued during this time.
After completing their studies at King George V College, Matthew Bambery enrolled in the University of Bristol. Matthew studied Chemistry and obtained a MSci (I) degree, which they earned between 1996 and 2000.
In addition to their academic qualifications, Matthew Bambery holds the certification of Fellow Chartered Accountant (FCA) from the ICAEW, although details regarding the specific year and month of obtaining this certification are unavailable.
November 1, 2023 - present
September, 2013